The US Justice Department has given the green light for German multinational Bayer to acquire Monsanto in a US$60bn-plus deal, following a series of divestments from both companies to allay anti-trust concerns. This is the latest nod of approval in the so-called “mega deal” which would make Bayer and Monsanto the world’s largest integrated pesticides and seeds company. Following the planned acquisition, the new company would have a share of more than a quarter of the world’s seed and pesticides market.
This is exactly what regulators have been concerned about and why both giants have gone about divesting parts of their businesses.
Bayer has offered up more concessions by selling some parts of its business to ease the passage such as the deal with German chemical company BASF, which has signed an agreement to acquire significant parts of Bayer’s seed and non-selective herbicide businesses.
And Bayer Chief Executive Werner Baumann has recently said in a statement that the company is “actively addressing observations expressed by antitrust authorities.”
“We have now also committed to divest our entire vegetable seed business. Certain additional business activities of Bayer and Monsanto may also be sold or out-licensed,” he said.
The Wall Street Journal claims that “people familiar with the matter” told them how the Justice Department had reached an agreement in principle with Bayer and Monsanto over recent days. However, there has yet to be an official announcement from the regulators or either company.
The approval from the US Justice Department closely follows Monsanto reporting disappointing sales and earnings for its fiscal second quarter as it sold less corn in the US.
The company has said that the results were partly due to the drop in planted acres in the US this season, as well as the impact of lower commodity prices in Brazil. However, shares of the world’s biggest seed company spiked following news of the Justice Department approval, closing yesterday (April 9) at US$125.15.
Plans for such major consolidation has sparked heavy opposition from environmentalists and some farming groups who are concerned about their market power.
However the Bayer-Monsanto tie-up is clearing regulatory hurdles, including earlier in March when the European Commission (EC) conditionally approved the acquisition – but it does come with conditions.
The EC says the merger is conditional on the divestiture of an extensive remedy package, which addresses the parties’ overlaps in seeds, pesticides and digital agriculture.
The conditions cover in particular the divestment of certain Bayer businesses, including the global field crop seeds business such as canola, cotton, and soybean (with minor exceptions restricted to the Asia region), the R&D platform for hybrid wheat, the global vegetable seeds business, the global glufosinate ammonium business as well as certain glyphosate-based herbicides in Europe, predominantly for industrial use.
Also, Monsanto’s global business with the nematicide NemaStrike must be divested.
By Gaynor Selby
Source: Food Ingredients First
A new wave of brands is emerging that promotes indulgence and rejects the notion of sacrifice. Low-maintenance “hangover” beauty products are designed to address the effects of late nights and partying without judgment or hassle, and even include cosmetics that are formulated in a way that means you can fall asleep in your makeup without feeling guilty.
The pilot will allow the company to scale circular packaging in about 18 markets over the next three years, an approach that jumps on the success of similar efforts in the company’s Indonesia ecoSPIRITS program, which launched in 2022 and is active in 38 bars.
Unilever’s focus on purpose across its brands has been a source of criticism from some of its investors. Its new CEO Hein Schumacher says the company now recognises there are some brands where the concept is simply not relevant.
